A phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis: Induced pluripotent stem cell-based drug repurposing for amyotrophic lateral sclerosis medicine (IDREAM) study
2021
Keywords:
- Correction
- Source
- Cite
- Save
0
References
0
Citations
NaN
KQI